home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Seeing Cancer Specifics

  December, 10 2008 20:15
your information resource in human molecular genetics

Fluorescence probes capable of selective molecular imaging of living cancer cells are reported in a paper online in Nature Medicine. The method reduces 'noise' from healthy cells and could potentially be adapted to other cancer specific molecules.

A goal of cancer diagnosis is to develop tumour-imaging techniques that have sufficient specificity and sensitivity. To achieve this, minimizing the background signal from healthy tissues is crucial. Yasuteru Urano and his colleagues achieve highly specific cancer visualization within the body by developing a probe that becomes fluorescent after its entry into the cell by sensing the acidic pH change characteristic of a certain part of the cell, known as lysosomes. The authors attached their pH-activated probe to a cancer-targeting antibody and showed that it was useful to image lung cancer cells in mice.

The probe was highly specific for tumours with minimal background signal. Furthermore, because the acidic pH in lysosomes disappears in dying or dead cells, only living cancer cells were successfully visualized. The design concept developed in this paper can in principle be adapted to any cancer-specific, cell surface-targeting molecule that enters a cell through lysosomes.

Author contact:

Yasuteru Urano (University of Tokyo, Japan)
E-mail: urano@mol.f.u-tokyo.ac.jp

Abstract available online.

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.